Ramazi Otarovich Datiashvili

Ramazi Datiashvili practices at University Hospital in Newark, New Jersey, part of State of New Jersey.

Ramazi Datiashvili's NPI, 1952466518, was assigned on December 26, 2006. Ramazi Datiashvili graduated from IM Sechenov Moscow Medical Academy in 1972. Ramazi Datiashvili holds New Jersey license 25MA06921300.

Ramazi Datiashvili's primary practice is University Hospital, at 150 Bergen St, Newark, NJ 07103 in Essex County. The practice phone is (973) 972-4300.

Ramazi Datiashvili's primary practice is University Hospital in Newark, New Jersey, part of State of New Jersey. The medical group on file is University Neuro-Ophthalmology Associates. Dmand AI also links Ramazi Datiashvili to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ramazi Datiashvili practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Ramazi Datiashvili's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Ramazi Datiashvili is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Ramazi Datiashvili's licenses on file in 2 states: New Jersey and New York.

CMS data shows 20 Medicare services from Ramazi Datiashvili across 1 procedure code in 2016, all of them office visits, for 15 Medicare patients. Medicare paid $1,401 for them. Every service was in an office.

CMS counts 15 Medicare patients who saw Ramazi Datiashvili in 2024. The largest group is 85 and over, with 0 patients. 75% of them have diabetes, and 75% have high blood pressure. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ramazi Datiashvili's median patient age at 45, with 45% women.

In 2019, Ramazi Datiashvili wrote 13 Medicare Part D claims. They cover 1 drug, with $111 in total drug cost. In 2017, CMS named 12 claims across 1 drug.

Ramazi Datiashvili accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 48 papers to Ramazi Datiashvili, published from 2011 to 2022. 2015 was the busiest year, with 6. The most frequent topics are Amputation, Traumatic, Replantation and Wound Healing. Ramazi Datiashvili has published most often in Eplasty. Ramazi Datiashvili's most frequent co-authors are Adam M. Feintisch, MD, Mark S. Granick, MD and Haripriya Ayyala, MD.

CMS Open Payments shows 12 general payments to Ramazi Datiashvili from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Integra LifeSciences Corporation paid the most, $120.

Ramazi Datiashvili graduated from IM Sechenov Moscow Medical Academy in 1972.

Ramazi Datiashvili is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.